RCSB PDB - LYS Ligand Summary Page

Chemical Component Summary
Name	LYSINE
Identifiers	[(5S)-5-amino-6-hydroxy-6-oxo-hexyl]azanium
Formula	C₆ H₁₅ N₂ O₂
Molecular Weight	147.19
Type	L-PEPTIDE LINKING
Isomeric SMILES	C(CC[NH3+])C[C@@H](C(=O)O)N
InChI	InChI=1S/C6H14N2O2/c7-4-2-1-3-5(8)6(9)10/h5H,1-4,7-8H2,(H,9,10)/p+1/t5-/m0/s1
InChIKey	KDXKERNSBIXSRK-YFKPBYRVSA-O

Chemical Details
Formal Charge	1
Atom Count	25
Chiral Atom Count	1
Bond Count	24
Aromatic Bond Count	0

Drug Info: DrugBank

DrugBank ID	DB00123
Name	L-Lysine
Groups	approved nutraceutical
Description	L-Lysine (abbreviated as Lys or K) is an α-amino acid with the chemical formula HO2CCH(NH2)(CH2)4NH2. This amino acid is an essential amino acid, which means that humans cannot synthesize it. Its codons are AAA and AAG. L-Lysine is a base, as are arginine and histidine. The ε-amino group acts as a site for hydrogen binding and a general base in catalysis. Common posttranslational modifications include methylation of the ε-amino group, giving methyl-, dimethyl-, and trimethyllysine. The latter occurs in calmodulin. Other posttranslational modifications include acetylation. Collagen contains hydroxylysine which is derived from lysine by lysyl hydroxylase. O-Glycosylation of lysine residues in the endoplasmic reticulum or Golgi apparatus is used to mark certain proteins for secretion from the cell.
Synonyms	L-lys Lysine L-Lysine hydrochloride (S)-2,6-diaminohexanoic acid L-Lysine acetate L-2,6-Diaminocaproic acid L-Lysin 6-ammonio-L-norleucine (S)-lysine LYS (S)-α,ε-diaminocaproic acid L-Lysine L-Lysine monohydrate Lysina Lysine acid Lysinum
Brand Names	Aminosyn II 7% With 10% Dextrose Primene 10%-liq IV RenAmin Plenamine Primene TrophAmine Aminosyn RF Aminosyn II 8.5% M In 20% Dextrose (dual Chamber) Smofkabiven 4.25% Travasol Amino Acid Injection Without Electrolytes In 25% Dextrose Aminosyn II 7% With 50% Dextrose Premasol - sulfite-free (Amino Acid) Aminosyn II with Electrolytes in Dextrose with Calcium Olimel 7.6% 2.5% Travasol Amino Acid Injection Without Electrolytes In 10% Dextrose Quickmix Travasol Amino Acid Inj 8.5% Aminosyn II 7% M In 10% Dextrose(dual Chamber) Effervescent Potassium Chloride 2.5%travasol Amino Acid InJ.W.eleC.W.25%dex FreAmine III HepatAmine Hepatasol Aminosyn II In Dextrose Injection Vamin N Aminosyn II 7% Injection Aminosyn 7% Aminosyn 5% Aminosyn II 10% With Electrolytes Travasol Olimel 4.4% E 4.25% Travasol Amino Acid Injection With Electrolytes In 25% Dextrose 2.5% Travasol Amino Acid Injection With Electrolytes In 10% Dextrose Smofkabiven Peripheral Aminosyn II Clinisol 2.75% Travasol Amino Acid Injection With Electrolytes In 25% Dextrose Quickmix Aminosyn 3.5% M Aminosyn II in Dextrose Novamine Renamin (amino Acids) Injection 4.25% Travasol Amino Acid Injection With Electrolytes In 5% Dextrose Quickmix Aminosyn II with Electrolytes Aminosyn-PF 7% 8.5% Freamine III Periolimel 2.5% E ProSol 4.25%trav. Amino Acid InJ.W.O.elect.5%dext. FreAmine HBC 4.25% Travasol Amino Acid Injection Without Electrlytes In 10% Dextrose 4.25% Travasol Amino Acid Injection With Electrolytes In 20% Dextrose Quickmix Travasol Inj Without Electrolytes 5.5% Clinimix Aminosyn 10% W Electrolytes Olimel 5.7% 2.75%travasol Amino Acid InJ.W.eleC.W.5%dex. 4.25% Travasol Amino Acid Without Electrolytes In 5% Dextrose Quickmix Clinimix 2.5% Travasol Aa Without Electrolytes In 10% Dextrose Injec Aminosyn II and Dextrose Quick Mix 2.5% Travasol Aa With Electrolytes With 25% Dextrose Injec Aminosyn HF Olimel 7.6% E Aminosyn-PF ProcalAmine Smofkabiven Extra Nitrogen Electrolyte Free Aminosyn 8.5% Nephramine Liq IV Travasol Inj Without Electrolytes 8.5% 20% Prosol 4.25% Amino Acid Injection Without Electrolytes In 20% Dextrose Quickmix Xyzmune Kabiven Smofkabiven Electrolyte Free Nutrineal Pd4 4.25% Travasol Amino Acid Injection Without Electrolytes In 20% Dextrose Primene 10% 4.25% Travasol Amino Acid Injection With Electrolytes In 10% Dextrose Olimel 4.4% 5% Travasol Amino Acid Injection Without Electrolytes In 20% Dextrose Aminosyn II 5% Inj Aminosyn II 8.5% With 50% Dextrose 2.75% Travasol Amino Acid Injection With Electrolytes In 5% Dextrose Quickmix Aminosyn-PF 10% Aminosyn RF Injection Travasol Amino Acid Inj 5.5% 4.25% Travasol Amino Acid Injection With Electrolytes In 20% Dextrose Olimel 3.3% E Perikabiven Aminosyn Sulfite Free Vamin 18 Electrolyte-free Travasol E Synthamin Aminosyn II 8.5% Injection 2.75% Travas. Amino Acid InJ.W.elecw.25%dex 2.5% Travasol Amino Acid Injection With Electrolytes In 10% Dextrose Clinimix Aminosyn Olimel 5.7% E 5% Travasol Amino Acid Injection Without Electrolytes In 25% Dextrose Aminosyn 8.5% Injection With Electrolytes NephrAmine Smofkabiven Extra Nitrogen Clinimix E 4.25%travasol Amino Acid InJ.W.elecw.5%dex. 5% Travasol Amino Acid Injection With Electrolytes In 20% Dextrose
Indication	Supplemental L-lysine has putative anti-herpes simplex virus activity. There is preliminary research suggesting that it may have some anti-osteoporotic activity.
Categories	Amino Acids Amino Acids, Basic Amino Acids, Diamino Amino Acids, Essential Amino Acids, Peptides, and Proteins Blood and Blood Forming Organs Blood Substitutes and Perfusion Solutions Detoxifying Agents for Antineoplastic Treatment Dietary Supplements I.V. Solution Additives Lysine Supplements
ATC-Code	V03AF11 B05XB03
CAS number	56-87-1

Drug Targets

Name	Target Sequence	Pharmacological Action	Actions
High affinity cationic amino acid transporter 1	MGCKVLLNIGQQMLRRKVVDCSREETRLSRCLNTFDLVALGVGSTLGAGV...	unknown
Cationic amino acid transporter 4	MARGLPTIASLARLCQKLNRLKPLEDSTMETSLRRCLSTLDLTLLGVGGM...	unknown
Cationic amino acid transporter 3	MPWQAFRRFGQKLVRRRTLESGMAETRLARCLSTLDLVALGVGSTLGAGV...	unknown
Low affinity cationic amino acid transporter 2	MIPCRAALTFARCLIRRKIVTLDSLEDTKLCRCLSTMDLIALGVGSTLGA...	unknown
Lysine--tRNA ligase	MAAVQAAEVKVDGSEPKLSKNELKRRLKAEKKVAEKEAKQKELSEKQLSQ...	unknown
Monocarboxylate transporter 10	MVLSQEEPDSARGTSEAQPLGPAPTGAAPPPGPGPSDSPEAAVEKVEVEL...	unknown	substrate,inhibitor
Solute carrier family 22 member 4	MRDYDEVIAFLGEWGPFQRLIFFLLSASIIPNGFNGMSVVFLAGTPEHRC...	unknown	inhibitor
View More

Drug Info/Drug Targets: DrugBank 3.0: a comprehensive resource for 'omics' research on drugs. Knox C, Law V, Jewison T, Liu P, Ly S, Frolkis A, Pon A, Banco K, Mak C, Neveu V, Djoumbou Y, Eisner R, Guo AC, Wishart DS. Nucleic Acids Res. 2011 Jan; 39 (Database issue):D1035-41. | PMID:21059682

Resource Name	Reference
CCDC/CSD	LYSASP
PubChem	5460926
PubChem	24848423
PubChem	641599
ChEBI	CHEBI:32551

174994 Biological Macromolecular Structures Enabling Breakthroughs in Research and Education

LYS

LYSINE

Chemical Component Summary

Chemical Details

Drug Info: DrugBank

Drug Targets

Related Resource References

Prepare Data

Validate Data

Deposit Data

Deposition Help & Resources

174994 Biological Macromolecular Structures Enabling Breakthroughs in Research and Education

LYS

LYSINE

Chemical Component Summary

Chemical Details

Drug Info: DrugBank

Drug Targets

Related Resource References